The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Virtual Clinical Trials Market Research Report 2024
Synopsis
Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.
The global Virtual Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Virtual Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Virtual Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Virtual Clinical Trials in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Virtual Clinical Trials include ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle and CRF Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Virtual Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Clinical Trials.
Report Scope
The Virtual Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Virtual Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virtual Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
Segment by Type
Interventional Trials
Observational Trials
Expanded Access Trials
Segment by Application
Oncology
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virtual Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.
The global Virtual Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Virtual Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Virtual Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Virtual Clinical Trials in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Virtual Clinical Trials include ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle and CRF Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Virtual Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Clinical Trials.
Report Scope
The Virtual Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Virtual Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virtual Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
Segment by Type
Interventional Trials
Observational Trials
Expanded Access Trials
Segment by Application
Oncology
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virtual Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Clinical Trials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Interventional Trials
1.2.3 Observational Trials
1.2.4 Expanded Access Trials
1.3 Market by Application
1.3.1 Global Virtual Clinical Trials Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virtual Clinical Trials Market Perspective (2019-2030)
2.2 Virtual Clinical Trials Growth Trends by Region
2.2.1 Global Virtual Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Virtual Clinical Trials Historic Market Size by Region (2019-2024)
2.2.3 Virtual Clinical Trials Forecasted Market Size by Region (2025-2030)
2.3 Virtual Clinical Trials Market Dynamics
2.3.1 Virtual Clinical Trials Industry Trends
2.3.2 Virtual Clinical Trials Market Drivers
2.3.3 Virtual Clinical Trials Market Challenges
2.3.4 Virtual Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Clinical Trials Players by Revenue
3.1.1 Global Top Virtual Clinical Trials Players by Revenue (2019-2024)
3.1.2 Global Virtual Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global Virtual Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Virtual Clinical Trials Revenue
3.4 Global Virtual Clinical Trials Market Concentration Ratio
3.4.1 Global Virtual Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Clinical Trials Revenue in 2023
3.5 Virtual Clinical Trials Key Players Head office and Area Served
3.6 Key Players Virtual Clinical Trials Product Solution and Service
3.7 Date of Enter into Virtual Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Clinical Trials Breakdown Data by Type
4.1 Global Virtual Clinical Trials Historic Market Size by Type (2019-2024)
4.2 Global Virtual Clinical Trials Forecasted Market Size by Type (2025-2030)
5 Virtual Clinical Trials Breakdown Data by Application
5.1 Global Virtual Clinical Trials Historic Market Size by Application (2019-2024)
5.2 Global Virtual Clinical Trials Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Virtual Clinical Trials Market Size (2019-2030)
6.2 North America Virtual Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Virtual Clinical Trials Market Size by Country (2019-2024)
6.4 North America Virtual Clinical Trials Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virtual Clinical Trials Market Size (2019-2030)
7.2 Europe Virtual Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Virtual Clinical Trials Market Size by Country (2019-2024)
7.4 Europe Virtual Clinical Trials Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Virtual Clinical Trials Market Size (2019-2030)
8.2 Asia-Pacific Virtual Clinical Trials Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Virtual Clinical Trials Market Size by Region (2019-2024)
8.4 Asia-Pacific Virtual Clinical Trials Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Virtual Clinical Trials Market Size (2019-2030)
9.2 Latin America Virtual Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Virtual Clinical Trials Market Size by Country (2019-2024)
9.4 Latin America Virtual Clinical Trials Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virtual Clinical Trials Market Size (2019-2030)
10.2 Middle East & Africa Virtual Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Virtual Clinical Trials Market Size by Country (2019-2024)
10.4 Middle East & Africa Virtual Clinical Trials Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON Plc
11.1.1 ICON Plc Company Detail
11.1.2 ICON Plc Business Overview
11.1.3 ICON Plc Virtual Clinical Trials Introduction
11.1.4 ICON Plc Revenue in Virtual Clinical Trials Business (2019-2024)
11.1.5 ICON Plc Recent Development
11.2 LEO Innovation Lab
11.2.1 LEO Innovation Lab Company Detail
11.2.2 LEO Innovation Lab Business Overview
11.2.3 LEO Innovation Lab Virtual Clinical Trials Introduction
11.2.4 LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2019-2024)
11.2.5 LEO Innovation Lab Recent Development
11.3 Science 37
11.3.1 Science 37 Company Detail
11.3.2 Science 37 Business Overview
11.3.3 Science 37 Virtual Clinical Trials Introduction
11.3.4 Science 37 Revenue in Virtual Clinical Trials Business (2019-2024)
11.3.5 Science 37 Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Detail
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Virtual Clinical Trials Introduction
11.4.4 PRA Health Sciences Revenue in Virtual Clinical Trials Business (2019-2024)
11.4.5 PRA Health Sciences Recent Development
11.5 Clinical Ink
11.5.1 Clinical Ink Company Detail
11.5.2 Clinical Ink Business Overview
11.5.3 Clinical Ink Virtual Clinical Trials Introduction
11.5.4 Clinical Ink Revenue in Virtual Clinical Trials Business (2019-2024)
11.5.5 Clinical Ink Recent Development
11.6 Parexel
11.6.1 Parexel Company Detail
11.6.2 Parexel Business Overview
11.6.3 Parexel Virtual Clinical Trials Introduction
11.6.4 Parexel Revenue in Virtual Clinical Trials Business (2019-2024)
11.6.5 Parexel Recent Development
11.7 Medable
11.7.1 Medable Company Detail
11.7.2 Medable Business Overview
11.7.3 Medable Virtual Clinical Trials Introduction
11.7.4 Medable Revenue in Virtual Clinical Trials Business (2019-2024)
11.7.5 Medable Recent Development
11.8 Oracle
11.8.1 Oracle Company Detail
11.8.2 Oracle Business Overview
11.8.3 Oracle Virtual Clinical Trials Introduction
11.8.4 Oracle Revenue in Virtual Clinical Trials Business (2019-2024)
11.8.5 Oracle Recent Development
11.9 CRF Health
11.9.1 CRF Health Company Detail
11.9.2 CRF Health Business Overview
11.9.3 CRF Health Virtual Clinical Trials Introduction
11.9.4 CRF Health Revenue in Virtual Clinical Trials Business (2019-2024)
11.9.5 CRF Health Recent Development
11.10 Medidata
11.10.1 Medidata Company Detail
11.10.2 Medidata Business Overview
11.10.3 Medidata Virtual Clinical Trials Introduction
11.10.4 Medidata Revenue in Virtual Clinical Trials Business (2019-2024)
11.10.5 Medidata Recent Development
11.11 Covance
11.11.1 Covance Company Detail
11.11.2 Covance Business Overview
11.11.3 Covance Virtual Clinical Trials Introduction
11.11.4 Covance Revenue in Virtual Clinical Trials Business (2019-2024)
11.11.5 Covance Recent Development
11.12 IQVIA
11.12.1 IQVIA Company Detail
11.12.2 IQVIA Business Overview
11.12.3 IQVIA Virtual Clinical Trials Introduction
11.12.4 IQVIA Revenue in Virtual Clinical Trials Business (2019-2024)
11.12.5 IQVIA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Virtual Clinical Trials Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Interventional Trials
Table 3. Key Players of Observational Trials
Table 4. Key Players of Expanded Access Trials
Table 5. Global Virtual Clinical Trials Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Virtual Clinical Trials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Virtual Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Virtual Clinical Trials Market Share by Region (2019-2024)
Table 9. Global Virtual Clinical Trials Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Virtual Clinical Trials Market Share by Region (2025-2030)
Table 11. Virtual Clinical Trials Market Trends
Table 12. Virtual Clinical Trials Market Drivers
Table 13. Virtual Clinical Trials Market Challenges
Table 14. Virtual Clinical Trials Market Restraints
Table 15. Global Virtual Clinical Trials Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Virtual Clinical Trials Market Share by Players (2019-2024)
Table 17. Global Top Virtual Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Clinical Trials as of 2023)
Table 18. Ranking of Global Top Virtual Clinical Trials Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Virtual Clinical Trials Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Virtual Clinical Trials Product Solution and Service
Table 22. Date of Enter into Virtual Clinical Trials Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Virtual Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Virtual Clinical Trials Revenue Market Share by Type (2019-2024)
Table 26. Global Virtual Clinical Trials Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Virtual Clinical Trials Revenue Market Share by Type (2025-2030)
Table 28. Global Virtual Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Virtual Clinical Trials Revenue Market Share by Application (2019-2024)
Table 30. Global Virtual Clinical Trials Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Virtual Clinical Trials Revenue Market Share by Application (2025-2030)
Table 32. North America Virtual Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Virtual Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Virtual Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Virtual Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Virtual Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Virtual Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Virtual Clinical Trials Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Virtual Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Virtual Clinical Trials Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Virtual Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Virtual Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Virtual Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Virtual Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Virtual Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Virtual Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 47. ICON Plc Company Detail
Table 48. ICON Plc Business Overview
Table 49. ICON Plc Virtual Clinical Trials Product
Table 50. ICON Plc Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 51. ICON Plc Recent Development
Table 52. LEO Innovation Lab Company Detail
Table 53. LEO Innovation Lab Business Overview
Table 54. LEO Innovation Lab Virtual Clinical Trials Product
Table 55. LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 56. LEO Innovation Lab Recent Development
Table 57. Science 37 Company Detail
Table 58. Science 37 Business Overview
Table 59. Science 37 Virtual Clinical Trials Product
Table 60. Science 37 Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 61. Science 37 Recent Development
Table 62. PRA Health Sciences Company Detail
Table 63. PRA Health Sciences Business Overview
Table 64. PRA Health Sciences Virtual Clinical Trials Product
Table 65. PRA Health Sciences Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 66. PRA Health Sciences Recent Development
Table 67. Clinical Ink Company Detail
Table 68. Clinical Ink Business Overview
Table 69. Clinical Ink Virtual Clinical Trials Product
Table 70. Clinical Ink Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 71. Clinical Ink Recent Development
Table 72. Parexel Company Detail
Table 73. Parexel Business Overview
Table 74. Parexel Virtual Clinical Trials Product
Table 75. Parexel Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 76. Parexel Recent Development
Table 77. Medable Company Detail
Table 78. Medable Business Overview
Table 79. Medable Virtual Clinical Trials Product
Table 80. Medable Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 81. Medable Recent Development
Table 82. Oracle Company Detail
Table 83. Oracle Business Overview
Table 84. Oracle Virtual Clinical Trials Product
Table 85. Oracle Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 86. Oracle Recent Development
Table 87. CRF Health Company Detail
Table 88. CRF Health Business Overview
Table 89. CRF Health Virtual Clinical Trials Product
Table 90. CRF Health Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 91. CRF Health Recent Development
Table 92. Medidata Company Detail
Table 93. Medidata Business Overview
Table 94. Medidata Virtual Clinical Trials Product
Table 95. Medidata Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 96. Medidata Recent Development
Table 97. Covance Company Detail
Table 98. Covance Business Overview
Table 99. Covance Virtual Clinical Trials Product
Table 100. Covance Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 101. Covance Recent Development
Table 102. IQVIA Company Detail
Table 103. IQVIA Business Overview
Table 104. IQVIA Virtual Clinical Trials Product
Table 105. IQVIA Revenue in Virtual Clinical Trials Business (2019-2024) & (US$ Million)
Table 106. IQVIA Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Virtual Clinical Trials Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Virtual Clinical Trials Market Share by Type: 2023 VS 2030
Figure 3. Interventional Trials Features
Figure 4. Observational Trials Features
Figure 5. Expanded Access Trials Features
Figure 6. Global Virtual Clinical Trials Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Virtual Clinical Trials Market Share by Application: 2023 VS 2030
Figure 8. Oncology Case Studies
Figure 9. Cardiovascular Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Virtual Clinical Trials Report Years Considered
Figure 12. Global Virtual Clinical Trials Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Virtual Clinical Trials Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Virtual Clinical Trials Market Share by Region: 2023 VS 2030
Figure 15. Global Virtual Clinical Trials Market Share by Players in 2023
Figure 16. Global Top Virtual Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Clinical Trials as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Virtual Clinical Trials Revenue in 2023
Figure 18. North America Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Virtual Clinical Trials Market Share by Country (2019-2030)
Figure 20. United States Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Virtual Clinical Trials Market Share by Country (2019-2030)
Figure 24. Germany Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Virtual Clinical Trials Market Share by Region (2019-2030)
Figure 32. China Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Virtual Clinical Trials Market Share by Country (2019-2030)
Figure 40. Mexico Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Virtual Clinical Trials Market Share by Country (2019-2030)
Figure 44. Turkey Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Virtual Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. ICON Plc Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 47. LEO Innovation Lab Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 48. Science 37 Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 49. PRA Health Sciences Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 50. Clinical Ink Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 51. Parexel Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 52. Medable Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 53. Oracle Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 54. CRF Health Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 55. Medidata Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 56. Covance Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 57. IQVIA Revenue Growth Rate in Virtual Clinical Trials Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
